Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration announced today it  approved Qiagen's Therascreen FGFR RGQ RT-PCR Kit as a companion diagnostic for Janssen Pharmaceutical's metastatic bladder cancer drug erdafitinib (Balversa) in a molecularly defined subpopulation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.